Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Marketing Surveillance on the Long-Term Use of Prazaxa® Capsules in Patients With Nonvalvular Atrial Fibrillation

NCT01491178 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT01491178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01491178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Marketing Surveillance on the Long-Term Use of Prazaxa® Capsules in Patients With Nonvalvular Atrial Fibrillation
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
December 12, 2011
Completion date
August 2, 2016
Enrollment
6,772 (actual)
Sites
1,164

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation